Creative Financial Designs’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-500
Closed -$15K – 1345
2022
Q3
$15K Buy
+500
New +$15.8K ﹤0.01% 801
2021
Q3
– Sell
-350
Closed -$17K – 1449
2021
Q2
$17K Sell
350
-400
-53% -$19.2K ﹤0.01% 902
2021
Q1
$38K Buy
750
+200
+36% +$11.1K 0.01% 626
2020
Q4
$28K Hold
550
– – 0.01% 647
2020
Q3
$23K Buy
+550
New +$22.7K 0.01% 631

Other funds holding SBIO

Creative Financial Designs's SBIO Position: Q4 2022 in Review

Creative Financial Designs sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2022, closing a stake of 500 shares — an estimated $15K sold.

Creative Financial Designs first reported a position in SBIO in Q3 2020 and held it in 5 quarters. The position peaked at $38K in Q1 2021. 49 funds tracked by Wall St. Rank hold SBIO as of Q4 2022.

  • Creative Financial Designs reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2022 after selling out during the quarter.
  • Creative Financial Designs sold 500 ALPS Medical Breakthroughs ETF shares in Q4 2022, an estimated $15K.
  • Creative Financial Designs first reported a position in ALPS Medical Breakthroughs ETF in Q3 2020 and held it in 5 quarters.
  • Creative Financial Designs's ALPS Medical Breakthroughs ETF position peaked at $38K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2022.

Based on Creative Financial Designs's 13F filing for Q4 2022, filed 1 Feb 2023.